Evidence map›Paper›PMID 42445252›Full record

ArticleFrontiers in pharmacology2026

A curriculum-integrated learning experience linking experimental pharmacology, cell culture and Nrf2-related gene expression analysis in undergraduate biotechnology education.

Cristina García-Bonillo, Sandra Atienzar-Aroca, Martín Pérez-Leal

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Cristina García-BonilloDepartment of Biosciences, Faculty of Health Sciences, Universidad Europea de Valencia, Valencia, Spain.
Sandra Atienzar-ArocaDepartment of Biosciences, Faculty of Health Sciences, Universidad Europea de Valencia, Valencia, Spain.
Martín Pérez-LealDepartment of Biosciences, Faculty of Health Sciences, Universidad Europea de Valencia, Valencia, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Undergraduate biotechnology education requires integrated, experiential approaches that help students connect pharmacological modulation, cellular models, molecular analysis and data interpretation within coherent biological problems. This study describes and evaluates a curriculum-integrated learning experience linking experimental pharmacology, cell culture and Nrf2-related gene expression analysis in third-year Biotechnology students. Methods: A total of 32 students participated in the survey-based evaluation. The activity used A549 cells, sulforaphane as an Nrf2-activating compound and tert-butyl hydroperoxide as a pro-oxidant stimulus. Students followed an integrated workflow combining treatment design, cell culture handling, Nrf2-related gene selection, PCR-based gene expression analysis and scientific writing. Perceived learning was assessed using paired pre-post Likert-scale items and analyzed with the Wilcoxon matched-pairs signed-rank test. Post-intervention perceptions, satisfaction and open-ended feedback were analyzed descriptively. Results: Students showed significant improvements in all five pre-post items assessing perceived confidence or familiarity ( Conclusion: This curriculum-integrated learning experience was associated with perceived gains across pharmacological, cellular and molecular components of a biotechnology workflow. The intervention may provide a transferable model for integrating experiential, research-oriented and competency-based learning in undergraduate biotechnology education.

Indexed as

curriculum integrationexperiential learningexperimental pharmacologygene expression analysisundergraduate biotechnology education

Identifiers

PMID42445252
PMCPMC13357193

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.